U.S. flag

An official website of the United States government

NM_000322.5(PRPH2):c.509del (p.Gly170fs) AND PRPH2-related disorder

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Aug 4, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001942617.3

Allele description [Variation Report for NM_000322.5(PRPH2):c.509del (p.Gly170fs)]

NM_000322.5(PRPH2):c.509del (p.Gly170fs)

Gene:
PRPH2:peripherin 2 [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
6p21.1
Genomic location:
Preferred name:
NM_000322.5(PRPH2):c.509del (p.Gly170fs)
HGVS:
  • NC_000006.12:g.42721827del
  • NG_009176.2:g.5795del
  • NM_000322.5:c.509delMANE SELECT
  • NP_000313.2:p.Gly170fs
  • NC_000006.11:g.42689564del
  • NC_000006.11:g.42689565del
Protein change:
G170fs
Links:
dbSNP: rs2152010910
NCBI 1000 Genomes Browser:
rs2152010910
Molecular consequence:
  • NM_000322.5:c.509del - frameshift variant - [Sequence Ontology: SO:0001589]

Condition(s)

Name:
PRPH2-related disorder
Synonyms:
PRPH2-Related Disorders; PRPH2-related condition
Identifiers:
MedGen: CN239395

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Help
Submission AccessionSubmitterReview Status
(Assertion method)		Clinical Significance
(Last evaluated)		OriginMethodCitations
SCV002135400Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))		Pathogenic
(Aug 4, 2023) 		germlineclinical testing

PubMed (13)
[See all records that cite these PMIDs]

Help

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Heterozygous 'null allele' mutation in the human peripherin/RDS gene.

Meins M, Grüning G, Blankenagel A, Krastel H, Reck B, Fuchs S, Schwinger E, Gal A.

Hum Mol Genet. 1993 Dec;2(12):2181-2. No abstract available.

PubMed [citation]
PMID:
8111389

A null mutation in the human peripherin/RDS gene in a family with autosomal dominant retinitis punctata albescens.

Kajiwara K, Sandberg MA, Berson EL, Dryja TP.

Nat Genet. 1993 Mar;3(3):208-12.

PubMed [citation]
PMID:
8485575
See all PubMed Citations (13)

Details of each submission

From Invitae, SCV002135400.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (13)

Description

ClinVar contains an entry for this variant (Variation ID: 1365300). This variant has not been reported in the literature in individuals affected with PRPH2-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Gly170Valfs*86) in the PRPH2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PRPH2 are known to be pathogenic (PMID: 8111389, 8485575, 8485576, 8675410, 16916875, 17504850, 22863181, 25675413, 26061163, 27365499, 29555955, 33546218). For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 12, 2024